Net Income (Annual) Chart

View Net Income (Annual) for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1995. Start Trial.
Date Value
December 31, 2025 -88.61M
December 31, 2024 -45.31M
December 31, 2023 -54.23M
December 31, 2022 -49.87M
December 31, 2021 -54.20M
December 31, 2020 -41.74M
December 31, 2019 -24.98M
December 31, 2018 -24.55M
December 31, 2017 -2.084M
December 31, 2016 -11.39M
December 31, 2015 -10.15M
December 31, 2014 -18.26M
December 31, 2013 -14.07M
December 31, 2012 -41.65M
December 31, 2011 -9.196M
December 31, 2010 -13.58M
Date Value
December 31, 2009 -11.66M
December 31, 2008 -13.63M
December 31, 2007 -10.22M
December 31, 2006 -7.044M
December 31, 2005 -6.514M
December 31, 2004 -5.414M
December 31, 2003 -3.725M
December 31, 2002 -2.225M
December 31, 2001 -3.158M
December 31, 2000 -2.940M
December 31, 1999 -3.461M
December 31, 1998 -2.616M
December 31, 1997 -2.883M
December 31, 1996 -1.506M
December 31, 1995 -1.474M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -8.413M
NuCana Plc -38.68M
Mereo BioPharma Group Plc -41.98M
Compass Pathways Plc -288.53M
HemoGenyx Pharmaceuticals Plc -12.87M